OTC Monograph System Needs Transparency, Communication – PCPC
This article was originally published in The Tan Sheet
Executive Summary
While FDA’s OTC drug monograph system is an “appropriate and rational framework” for regulating cosmetic-drug products, greater transparency and more regular communication with industry are needed, according to Personal Care Products Council executive Elizabeth Anderson.